The overexpression (>10-fold) of MUC1 is often associated with a variety of malignant tumors, including breast, gastric, colorectal, lung, prostate, ovarian, pancreatic, and bladder carcinomas4, making MUC1 an ideal target molecule for tumor labeling and chemotherapeutics. The gene discussed is MUC1; the disease is neoplasm.